MAML2 and mucoepidermoid carcinoma: A significant finding was the lack of enhancer activity in the MAML2 gene, linked to translocations (forming fusion genes such as CRTC1-MAML2, a known oncogenic driver in mucoepidermoid carcinoma), enhancer mutations, DNA methylation or histone acetylation changes, which downregulated MAML2.